drug · small molecule
patient view →zipalertinib
pre_registrationupdated 2mo agoby Taiho Pharmaceutical Co Ltd🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3, with 1 investigational indication.
indications
indications
NSCLC
targets
Epidermal growth factor receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that